Usana Health Sciences
USNA
149 hedge funds and large institutions have $609M invested in Usana Health Sciences in 2016 Q4 according to their latest regulatory filings, with 24 funds opening new positions, 50 increasing their positions, 50 reducing their positions, and 14 closing their positions.
71% more first-time investments, than exits
New positions opened: 24 | Existing positions closed: 14
6% more funds holding
Funds holding: 140 → 149 (+9)
0% more repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 50
12% less capital invested
Capital invested by funds: $693M → $609M (-$84.2M)
43.32% less ownership
Funds ownership: 84.1% → 40.78% (-43%)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFC
Phocas Financial Corp
Alameda,
California
|
+$3.74M |
| 2 |
Charles Schwab
San Francisco,
California
|
+$3.4M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$3.13M |
| 4 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
+$3.05M |
| 5 |
TA
Teachers Advisors
New York
|
+$2.25M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Two Sigma Investments
New York
|
-$7.87M |
| 2 |
Millennium Management
New York
|
-$5.91M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$4.52M |
| 4 |
Goldman Sachs
New York
|
-$3.82M |
| 5 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
-$3.73M |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
DA
151
Denali Advisors
San Diego,
California
| – | -$2.19M | -31,710 | Closed |
|
|
OAM
152
Oxford Asset Management
Oxford,
United Kingdom
| – | -$1.67M | -24,080 | Closed |
|
|
DC
153
Deere & Company
Moline,
Illinois
| – | -$1.54M | -22,328 | Closed |
|
154
Arrowstreet Capital
Boston,
Massachusetts
| – | -$1.04M | -15,022 | Closed |
|
|
JIM
155
Jensen Investment Management
Lake Oswego,
Oregon
| – | -$490K | -7,080 | Closed |
|
156
UBS AM
Chicago,
Illinois
| – | -$454K | -6,566 | Closed |
|
|
GT
157
Glenmede Trust
Philadelphia,
Pennsylvania
| – | -$433K | -6,286 | Closed |
|
|
NI
158
Numeric Investors
Boston,
Massachusetts
| – | -$387K | -5,600 | Closed |
|
|
OAM
159
Origin Asset Management
London,
United Kingdom
| – | -$317K | -4,578 | Closed |
|
|
SI
160
Sensato Investors
San Francisco,
California
| – | -$233K | -3,364 | Closed |
|
|
BBPWM
161
Blue Bell Private Wealth Management
Blue Bell,
Pennsylvania
| – | -$70K | -1,000 | Closed |
|
|
IWMPD
162
Integrated Wealth Management (Palm Desert)
Palm Desert,
California
| – | -$16K | -238 | Closed |
|
USNA Hedge Fund Activity: Q4 2016 in Review
149 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Usana Health Sciences (USNA) for Q4 2016, worth a combined $609M — down 12% from $693M a quarter earlier.
Buyers outnumbered sellers: 24 funds opened new USNA positions and 14 closed out — a net gain of 10 holders — while 50 added to existing stakes and 50 trimmed.
The largest buyer was Phocas Financial Corp, adding an estimated $3.74M. The largest seller was Two Sigma Investments, exiting entirely with an estimated $7.87M sold.
- 149 institutional investors held Usana Health Sciences (USNA) as of Q4 2016, up from 140 in Q3 2016.
- Funds reported $609M of Usana Health Sciences stock for Q4 2016, down 12% quarter-over-quarter.
- 24 funds opened new Usana Health Sciences positions in Q4 2016 and 14 closed out, a net change of +10 holders.
- The largest Usana Health Sciences buyer in Q4 2016 was Phocas Financial Corp, an estimated $3.74M added.
- The largest Usana Health Sciences seller in Q4 2016 was Two Sigma Investments, an estimated $7.87M sold.
Based on aggregated 13F filings for Q4 2016.